4.4 Article

A rapid and flexible microneutralization assay for serological assessment of influenza viruses

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022

Mark W. Tenforde et al.

Summary: During the 2021-2022 US influenza season, circulating A(H3N2) viruses were antigenically different from the vaccine. The vaccine effectiveness against hospitalized illness was 26% (95% CI: -14-52%) for adults 18-64 years old and -3% (95% CI: -54-31%) for adults ≥ 65 years old. Our study showed that the influenza vaccine had some effectiveness in preventing hospitalization among immunocompetent adults aged 18-64, but provided no significant protection for adults ≥ 65.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Burden of medically attended influenza infection and cases averted by vaccination-United States, 2016/17 through 2018/19 influenza seasons

Michael L. Jackson et al.

Summary: This study estimated the number of influenza cases averted by vaccination in four ambulatory care sites in the United States, and it found that influenza vaccines can still reduce ambulatory care visits for influenza even in seasons with low vaccine effectiveness.

VACCINE (2022)

Article Immunology

Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020

Mark W. Tenforde et al.

Summary: This study investigated the vaccine effectiveness against emerging influenza viruses during the 2019-2020 season in the United States. The results showed that the vaccine provided good protection against B/Victoria viruses, but lower effectiveness against A(H1N1)pdm09 viruses, mainly due to vaccine mismatch caused by antigenic drift. The study observed the impact of antigenic drift on vaccine protection, with significant protection still observed even in drifted years.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season

Jessie R. Chung et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study

Arnold S. Monto et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)

Review Biotechnology & Applied Microbiology

H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation

James D. Allen et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Review Immunology

Efforts to Improve the Seasonal Influenza Vaccine

Alfred T. Harding et al.

VACCINES (2018)

Article Multidisciplinary Sciences

Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

Seth J. Zost et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Infectious Diseases

A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A

Shaun Truelove et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2016)

Editorial Material Multidisciplinary Sciences

Viral destruction of cell surface receptors

Andrew D. Mesecar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)